Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-01-04

Clinical Trial Update: The Multi-Center Clinical Study of Tang Shen Prescription on Type 2 Diabetic Kidney Disease in Early Stage [EARLY_Phase 1]

View source ↗

Summary

A multi-center clinical study update on Tang Shen Prescription for early-stage diabetic kidney disease in a Phase 1 trial; status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tang Shen Prescription

Snippet

Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Conditions: Diabetic Kidney Disease | EARLY_Phase 1 | Status: UNKNOWN